The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1226
January 16, 2006
View Complete Issue         Table of Contents 2019 
Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults
January 16, 2006 (Issue: 1226)
The FDA has licensed Adacel (Aventis Pasteur) and Boostrix (GlaxoSmithKline), two new combination vaccines that include tetanus toxoid, diphtheria toxoid and acellular pertussis antigens (Tdap), for use as a booster in adolescents and adults. In the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Adacel and Boostrix: Tdap Vaccines for Adolescents and Adults
Article code: 1226a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.